Investor Video
Click here to view interview with CEO Matthew Walls, as he gives an introduction to the company, reasons behind their IPO and what to expect from them over the next couple of years
GENinCode test products have been developed to help physicians make improved clinical decisions.
By delivering comprehensive risk assessment we are able to stratify patients and identify the most appropriate treatment pathways aligned with clinical guidelines to ensure optimal outcome.
Stay up to date on our shareholder news, view our financial performance and shareholder services.
Click here to view interview with CEO Matthew Walls, as he gives an introduction to the company, reasons behind their IPO and what to expect from them over the next couple of years